ArticleCureus2026
Exertional Rhabdomyolysis, Hyposthenuria, and Acute Kidney Injury: The Non-benign Side of Sickle Cell Trait.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell trait (SCT) is largely understood to be a clinically silent disease that typically does not require intensive clinical monitoring or counseling of patients. In fact, many patients with SCT are unaware that they have this genetic condition. However, emerging studies, case reports, and reviews increasingly demonstrate that severe clinical pathology can be associated with SCT, showcasing the need for improved counseling and education. We present the case of a healthy young male patient who was admitted to the hospital with rhabdomyolysis, acute liver injury, extreme electrolyte disturbances, and acute renal failure necessitating emergent hemodialysis. Given that this was an otherwise healthy young athlete with no known risk factors, the gravity of his clinical condition led our team to question why he had such a severe presentation. Further evaluation revealed the diagnosis of SCT. SCT has been linked to an increased risk of exertional rhabdomyolysis, which causes muscle damage via microvascular occlusion as well as tissue ischemia, caused by endothelial damage. These processes predispose to a decreased ability to concentrate urine, increasing risk for dehydration, and more serious clinical presentations. The potential links between SCT and exertional rhabdomyolysis support the hypothesis that SCT is not a clinically silent condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.